Relationship between oxidative stress, ER stress, and inflammation in type 2 diabetes: the battle continues

E Burgos-Morón, Z Abad-Jiménez… - Journal of clinical …, 2019 - mdpi.com
Type 2 diabetes (T2D) is a metabolic disorder characterized by hyperglycemia and insulin
resistance in which oxidative stress is thought to be a primary cause. Considering that …

Oxidative stress and NRF2/KEAP1/ARE pathway in diabetic kidney disease (DKD): new perspectives

DM Tanase, EM Gosav, MI Anton, M Floria… - Biomolecules, 2022 - mdpi.com
Diabetes mellitus (DM) is one of the most debilitating chronic diseases worldwide, with
increased prevalence and incidence. In addition to its macrovascular damage, through its …

NRF2, a Superstar of Ferroptosis

R Yan, B Lin, W Jin, L Tang, S Hu, R Cai - Antioxidants, 2023 - mdpi.com
Ferroptosis is an iron-dependent and lipid peroxidation-driven cell death cascade, occurring
when there is an imbalance of redox homeostasis in the cell. Nuclear factor erythroid 2 …

Oxidative stress and renal fibrosis: mechanisms and therapies

H Su, C Wan, A Song, Y Qiu, W Xiong… - … Fibrosis: Mechanisms and …, 2019 - Springer
Oxidative stress results from the disruption of the redox system marked by a notable
overproduction of reactive oxygen species. There are four major sources of reactive oxygen …

Is target-based drug discovery efficient? Discovery and “off-target” mechanisms of all drugs

A Sadri - Journal of medicinal chemistry, 2023 - ACS Publications
Target-based drug discovery is the dominant paradigm of drug discovery; however, a
comprehensive evaluation of its real-world efficiency is lacking. Here, a manual systematic …

Effects of glucagon-like peptide-1 on oxidative stress and Nrf2 signaling

YS Oh, HS Jun - International journal of molecular sciences, 2017 - mdpi.com
Oxidative cellular damage caused by free radicals is known to contribute to the
pathogenesis of various diseases such as cancer, diabetes, and neurodegenerative …

Activation of Nrf2 signaling by sitagliptin and quercetin combination against β‐amyloid induced Alzheimer's disease in rats

Y Li, Q Tian, Z Li, M Dang, Y Lin… - Drug development …, 2019 - Wiley Online Library
The objective of this study was to evaluate the neuroprotective effect of sitagliptin (Sita),
quercetin (QCR) and its combination in β‐amyloid (Aβ) induced Alzheimer's disease (AD) …

Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives

Y Wang, M Jin, CK Cheng, Q Li - Frontiers in Endocrinology, 2023 - frontiersin.org
Diabetic kidney disease (DKD) is a chronic complication of diabetes and the leading cause
of end-stage renal disease (ESRD) worldwide. Currently, there are limited therapeutic drugs …

Allisartan isoproxil attenuates oxidative stress and inflammation through the SIRT1/Nrf2/NF‑κB signalling pathway in diabetic cardiomyopathy rats

Q Jin, Q Zhu, K Wang, M Chen… - Molecular Medicine …, 2021 - spandidos-publications.com
Allisartan isoproxil is a new nonpeptide angiotensin II receptor blocker (ARB) precursor drug
that is used to treat hypertension and reduce the risk of heart disease. The present study …

MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment

H Yaribeygi, N Katsiki, B Behnam, H Iranpanah… - Metabolism, 2018 - Elsevier
The incidence of type 2 diabetes mellitus (T2DM), the most prevalent metabolic disease, is
rapidly growing worldwide. T2DM has several underlying causes involved in its …